Onivyde 43 mg/10 mL liposome injection Images

Generic Name: irinotecan liposomal

This medication has been identified as Onivyde 43 mg/10 mL liposome injection. It is supplied by Ipsen Biopharmaceuticals, Inc.

Onivyde is used in the treatment of Pancreatic Cancer and belongs to the drug class miscellaneous antineoplastics. Onivyde 43 mg/10 mL liposome injection is not a controlled substance under the Controlled Substances Act (CSA).

Images of medication

Onivyde

Generic Name

irinotecan liposomal

Strength

43 mg/10 mL liposome injection

Availability

Prescription only

Drug Class

Miscellaneous antineoplastics

CSA Schedule

Not a controlled drug

Labeler / Supplier

Ipsen Biopharmaceuticals, Inc.

National Drug Code (NDC)

15054-0043

Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer